MTNB
Price
$3.17
Change
-$0.12 (-3.65%)
Updated
Oct 9 closing price
27 days until earnings call
PHIO
Price
$2.89
Change
+$0.08 (+2.85%)
Updated
Oct 9 closing price
Ad is loading...

MTNB vs PHIO

Header iconMTNB vs PHIO Comparison
Open Charts MTNB vs PHIOBanner chart's image
Matinas Biopharma Holdings
Price$3.17
Change-$0.12 (-3.65%)
Volume$30.59K
CapitalizationN/A
Phio Pharmaceuticals
Price$2.89
Change+$0.08 (+2.85%)
Volume$14.44K
CapitalizationN/A
View a ticker or compare two or three
MTNB vs PHIO Comparison Chart
Loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MTNB vs. PHIO commentary
Oct 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTNB is a Hold and PHIO is a Sell.

COMPARISON
Comparison
Oct 10, 2024
Stock price -- (MTNB: $3.17 vs. PHIO: $2.89)
Brand notoriety: MTNB and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTNB: 3% vs. PHIO: 30%
Market capitalization -- MTNB: $17.91M vs. PHIO: $2.97M
MTNB [@Biotechnology] is valued at $17.91M. PHIO’s [@Biotechnology] market capitalization is $2.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTNB’s FA Score shows that 1 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • MTNB’s FA Score: 1 green, 4 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, MTNB is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 5 TA indicator(s) are bullish.

  • PHIO’s TA Score: 5 bullish, 5 bearish.

Price Growth

MTNB (@Biotechnology) experienced а +3.29% price change this week, while PHIO (@Biotechnology) price change was -9.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

MTNB is expected to report earnings on Nov 06, 2024.

PHIO is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTNB($17.9M) has a higher market cap than PHIO($2.97M). PHIO YTD gains are higher at: -57.749 vs. MTNB (-70.666). PHIO has higher annual earnings (EBITDA): -8.55M vs. MTNB (-22.8M). MTNB has more cash in the bank: 6.22M vs. PHIO (4.7M). PHIO has less debt than MTNB: PHIO (0) vs MTNB (3.24M). MTNB (0) and PHIO (0) have equivalent revenues.
MTNBPHIOMTNB / PHIO
Capitalization17.9M2.97M603%
EBITDA-22.8M-8.55M267%
Gain YTD-70.666-57.749122%
P/E RatioN/A0.01-
Revenue00-
Total Cash6.22M4.7M132%
Total Debt3.24M0-
FUNDAMENTALS RATINGS
MTNB vs PHIO: Fundamental Ratings
MTNB
PHIO
OUTLOOK RATING
1..100
367
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9365
P/E GROWTH RATING
1..100
10079
SEASONALITY SCORE
1..100
5n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for PHIO (61). This means that MTNB’s stock grew somewhat faster than PHIO’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PHIO (100). This means that MTNB’s stock grew similarly to PHIO’s over the last 12 months.

MTNB's SMR Rating (98) in the Biotechnology industry is in the same range as PHIO (98). This means that MTNB’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's Price Growth Rating (65) in the Biotechnology industry is in the same range as MTNB (93). This means that PHIO’s stock grew similarly to MTNB’s over the last 12 months.

PHIO's P/E Growth Rating (79) in the Biotechnology industry is in the same range as MTNB (100). This means that PHIO’s stock grew similarly to MTNB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHIO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
+2.85%
MTNB - PHIO
50%
Loosely correlated
-3.62%
TPST - PHIO
49%
Loosely correlated
-2.88%
IMNN - PHIO
39%
Loosely correlated
+1.50%
MDWD - PHIO
35%
Loosely correlated
+1.16%
BCYC - PHIO
33%
Loosely correlated
+4.46%
More